86 related articles for article (PubMed ID: 22308685)
21. Drug release and adhesive properties of crospovidone-containing matrix patches based on polyisobutene and acrylic adhesives.
Schulz M; Fussnegger B; Bodmeier R
Eur J Pharm Sci; 2010 Dec; 41(5):675-84. PubMed ID: 20883778
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of solid lipid nanoparticles loaded with alpha-Asarone.
Wang D; Wang X; Li X; Ye L
PDA J Pharm Sci Technol; 2008; 62(1):56-65. PubMed ID: 18402368
[TBL] [Abstract][Full Text] [Related]
23. Rheological studies on pressure-sensitive silicone adhesives and drug-in-adhesive layers as a means to characterise adhesive performance.
Ho KY; Dodou K
Int J Pharm; 2007 Mar; 333(1-2):24-33. PubMed ID: 17049768
[TBL] [Abstract][Full Text] [Related]
24. Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system.
Park CW; Son DD; Kim JY; Oh TO; Ha JM; Rhee YS; Park ES
Int J Pharm; 2012 Oct; 436(1-2):32-40. PubMed ID: 22771734
[TBL] [Abstract][Full Text] [Related]
25. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
Young CR; Koleng JJ; McGinity JW
J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
[TBL] [Abstract][Full Text] [Related]
26. A novel transdermal drug delivery system based on self-adhesive Janus nanofibrous film with high breathability and monodirectional water-penetration.
Shi Y; Li Y; Wu J; Wang W; Dong A; Zhang J
J Biomater Sci Polym Ed; 2014; 25(7):713-28. PubMed ID: 24641249
[TBL] [Abstract][Full Text] [Related]
27. Formulation and in vitro/in vivo correlation of a drug-in-adhesive transdermal patch containing azasetron.
Sun L; Cun D; Yuan B; Cui H; Xi H; Mu L; Chen Y; Liu C; Wang Z; Fang L
J Pharm Sci; 2012 Dec; 101(12):4540-8. PubMed ID: 22972714
[TBL] [Abstract][Full Text] [Related]
28. Creating Drug Solubilization Compartments via Phase Separation in Multicomponent Buccal Patches Prepared by Direct Hot Melt Extrusion-Injection Molding.
Alhijjaj M; Bouman J; Wellner N; Belton P; Qi S
Mol Pharm; 2015 Dec; 12(12):4349-62. PubMed ID: 26551593
[TBL] [Abstract][Full Text] [Related]
29. Adhesive properties: a critical issue in transdermal patch development.
Cilurzo F; Gennari CG; Minghetti P
Expert Opin Drug Deliv; 2012 Jan; 9(1):33-45. PubMed ID: 22171789
[TBL] [Abstract][Full Text] [Related]
30. GC-MS method for determination and pharmacokinetic study of four phenylpropanoids in rat plasma after oral administration of the essential oil of Acorus tatarinowii Schott rhizomes.
Wang Z; Wang Q; Yang B; Li J; Yang C; Meng Y; Kuang H
J Ethnopharmacol; 2014 Sep; 155(2):1134-40. PubMed ID: 25046827
[TBL] [Abstract][Full Text] [Related]
31. Application of confocal laser scanning microscopy in characterization of chemical enhancers in drug-in-adhesive transdermal patches.
Qvist MH; Hoeck U; Kreilgaard B; Madsen F; Hovgaard L; Frokjaer S
AAPS PharmSci; 2002; 4(1):E3. PubMed ID: 12049487
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of beta-asarone in rabbit blood, hippocampus, cortex, brain stem, thalamus and cerebellum.
Fang YQ; Shi C; Liu L; Fang RM
Pharmazie; 2012 Feb; 67(2):120-3. PubMed ID: 22512081
[TBL] [Abstract][Full Text] [Related]
33. Designing and characterizing of tramadol hydrochloride transdermal patches prepared with Ficus carica fruit mucilage and povidone.
Ahad HA; Ishaq BM; Shaik M; Bandagisa F
Pak J Pharm Sci; 2016 May; 29(3):945-51. PubMed ID: 27166538
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacokinetics of beta-asarone in rats].
Wu HB; Fang YQ
Yao Xue Xue Bao; 2004 Oct; 39(10):836-8. PubMed ID: 15700827
[TBL] [Abstract][Full Text] [Related]
35. Formulation and characterization of a captopril ethyl ester drug-in-adhesive-type patch for percutaneous absorption.
Gullick DR; Pugh WJ; Ingram MJ; Cox PA; Moss GP
Drug Dev Ind Pharm; 2010 Aug; 36(8):926-32. PubMed ID: 20184419
[TBL] [Abstract][Full Text] [Related]
36. Influence of poly(ethylene glycol)-alpha-cyclodextrin complexes on stabilization and transdermal permeation of ascorbic acid.
Davaran S; Hanaee J; Rashidi MR; Valiolah F; Hashemi M
J Biomed Mater Res A; 2006 Sep; 78(3):590-4. PubMed ID: 16739182
[TBL] [Abstract][Full Text] [Related]
37. In vitro transdermal delivery of caffeine, theobromine, theophylline and catechin from extract of Guarana, Paullinia Cupana.
Heard CM; Johnson S; Moss G; Thomas CP
Int J Pharm; 2006 Jul; 317(1):26-31. PubMed ID: 16600539
[TBL] [Abstract][Full Text] [Related]
38. On the characterization of medicated plasters containing NSAIDs according to novel indications of USP and EMA: adhesive property and in vitro skin permeation studies.
Cilurzo F; Gennari CG; Selmin F; Franzé S; Musazzi UM; Minghetti P
Drug Dev Ind Pharm; 2015 Feb; 41(2):183-9. PubMed ID: 24164486
[TBL] [Abstract][Full Text] [Related]
39. Distribution of α-asarone in brain following three different routes of administration in rats.
Lu J; Fu T; Qian Y; Zhang Q; Zhu H; Pan L; Guo L; Zhang M
Eur J Pharm Sci; 2014 Oct; 63():63-70. PubMed ID: 25008114
[TBL] [Abstract][Full Text] [Related]
40. In vitro evaluation of transdermal patches of flurbiprofen with ethyl cellulose.
Idrees A; Rahman NU; Javaid Z; Kashif M; Aslam I; Abbas K; Hussain T
Acta Pol Pharm; 2014; 71(2):287-95. PubMed ID: 25272649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
